Financial reports
ARS
2023 FY
Annual report to shareholders
15 Apr 24
10-K
2023 FY
Annual report
25 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
20 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Sanara MedTech Inc. Announces $55 Million Debt Facility
18 Apr 24
8-K
Departure of Directors or Certain Officers
5 Apr 24
8-K
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
25 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
22 Mar 24
8-K
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
22 Feb 24
8-K
Sanara MedTech Inc. Announces Third Quarter 2023 Results
13 Nov 23
8-K
Regulation FD Disclosure
19 Sep 23
8-K
Regulation FD Disclosure
16 Aug 23
8-K
Sanara MedTech Inc. Announces Second Quarter 2023 Results
14 Aug 23
8-K
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
2 Aug 23
Registration and prospectus
D
$3.00 mm in equity, sold $3.00 mm, 1 investor
11 Aug 23
424B5
Prospectus supplement for primary offering
24 Feb 23
S-8
Registration of securities for employees
26 Aug 22
D
$16M in equity, sold $16M, 1 investor
14 Jul 22
D
$14.5M in equity, sold $14.5M, 46 investors
2 Jun 22
D
$500K in equity, sold $500K, 1 investor
27 Jul 21
424B5
Prospectus supplement for primary offering
16 Feb 21
424B5
Prospectus supplement for primary offering
11 Feb 21
D
$1.07M in equity, sold $1.07M, 2 investors
25 Jan 21
S-3
Shelf registration
23 Dec 20
Proxies
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
PRE 14A
Preliminary proxy
5 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
13 Sep 21
DEF 14A
Definitive proxy
30 Aug 21
Other
EFFECT
Notice of effectiveness
5 Jan 21
UPLOAD
Letter from SEC
30 Dec 20
CORRESP
Correspondence with SEC
30 Dec 20
CERT
Certification of approval for exchange listing
30 Oct 20
UPLOAD
Letter from SEC
7 Jul 14
CORRESP
Correspondence with SEC
1 Jul 14
UPLOAD
Letter from SEC
25 Jun 14
UPLOAD
Letter from SEC
21 Oct 10
UPLOAD
Letter from SEC
19 Oct 10
UPLOAD
Letter from SEC
19 Oct 10
Ownership